Skip to main content

Table 8 Top 20 cited articles on vaccine – related publication on studied diseases

From: Global research trends of World Health Organization’s top eight emerging pathogens

Title Year Journal Number of citations
Development of a preventive vaccine for Ebola virus infection in primates [111] 2000 Nature 490
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates [112] 2003 Nature 336
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses [113] 2005 Nature Medicine 320
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice [114] 2004 Nature 320
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice [115] 2004 PNAS 232
Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates [116] 1998 Virology 199
Effects of a SARS-associated coronavirus vaccine in monkeys [117] 2003 Lancet 168
Ebola virus: From discovery to vaccine [118] 2003 Nature Reviews Immunology 168
Evaluation in nonhuman primates of vaccines against Ebola virus [119] 2002 Emerging Infectious Diseases 166
Severe acute respiratory syndrome vaccine development: Experiences of vaccination against avian infectious bronchitis coronavirus [120] 2003 Avian Pathology 152
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge [121] 2007 Journal of Infectious Diseases 149
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial [122] 2015 The Lancet 137
DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge [123] 1998 Virology 136
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial [124] 2006 Clinical and Vaccine Immunology 134
Single-injection vaccine protects nonhuman primates against infection with Marburg virus and three species of Ebola virus [125] 2009 Journal of Virology 127
Development of a new vaccine for the prevention of Lassa fever [126] 2005 PLoS Medicine 115
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: Implication for developing subunit vaccine [127] 2004 Biochemical and Biophysical Research Communications 115
Correlates of protective immunity for Ebola vaccines: Implications for regulatory approval by the animal rule [128] 2009 Nature Reviews Microbiology 105
Nipah Virus: Vaccination and Passive Protection Studies in a Hamster Model [129] 2004 Journal of Virology 105
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region [130] 2005 Journal of Virology 101
  1. PNAS Proceedings of the National Academy of Sciences